Avant Diagnostics

Industry

Medical Diagnostics

Years of investment

2017

Company description

Avant Diagnostics is a medical diagnostic and information technology company focused on commercializing innovative biomarker technologies coupled with personalized, precision healthcare recommendations. Avant is initially focused on oncology patients, and will expand into the chronic disease market.

Impediments to Success

  1. Management unequipped to grow value of proprietary technology
  2. Ineffective cash flow management
  3. Missing company differentiation and clear product positioning

How We Helped

  1. Brought investable capital and actionable plans
  2. Installed new CEO with a renowned track record
  3. Replaced Board of Directors
  4. In process of rebranding highly innovative offerings

 

www.avantdiagnostics.com

Vivacitas Oncology

Industry

Biopharmaceuticals

Years of investment

2016

Company description

Vivacitas is an acquirer and developer of biopharmaceutical projects, focused on re-designing established chemotherapies that have already been demonstrated to have beneficial effects, but which may also possess potency, toxicity, stability and/or pharmacokinetic issues that limit their use.

Impediments to Success

  1. Difficulties integrating 3 acquired assets into a newly formed company, Vivacitas
  2. Lack of organizational coherence and structure
  3. Incomplete asset transfer
  4. Lacking updated development / commercialization plans
  5. Missing company differentiation and clear product positioning

How We Helped

  1. Formed executive team and distinguished clinical advisory board
  2. Implemented effective organizational structure
  3. Finalized asset transfers
  4. Identified unique differentiating factors and product positioning
  5. Completed portfolio valuation

 

www.vivaoncology.com